Treatment of Peripheral Neuropathy in Non-Diabetic Elderly Males
Diagnostic Approach
- The American Diabetes Association recommends assessing for small fiber function (pinprick and temperature sensation) and large fiber function (vibration perception using 128-Hz tuning fork) for diagnosing peripheral neuropathy 1
- Conducting 10-g monofilament testing is recommended to identify risk for foot ulceration in patients with peripheral neuropathy 2
Treatment Algorithm
- The American College of Physicians recommends pregabalin (100-300 mg three times daily) as a first-line pharmacological option for treating peripheral neuropathy, with strong evidence for its efficacy 3
- The American Geriatrics Society recommends duloxetine (60-120 mg daily) as a first-line pharmacological option for treating peripheral neuropathy, due to its proven efficacy and lower risk of anticholinergic effects compared to tricyclic antidepressants 1, 4
- Gabapentin (300-1,200 mg three times daily) is recommended as a first-line pharmacological option for treating peripheral neuropathy, with a starting dose of 100-300 mg daily in elderly patients and slow titration 3, 4
- Tricyclic antidepressants (10-75 mg at bedtime) are recommended as a first-line pharmacological option for treating peripheral neuropathy, but should be used with caution in elderly patients due to anticholinergic effects, sedation, and cardiac risks 3, 4
Special Considerations for Elderly Patients
- The American Geriatrics Society recommends starting medications at lower doses and titrating slowly to minimize adverse effects in elderly patients with peripheral neuropathy 3
- Regular evaluation of treatment efficacy and adjustment as needed is recommended for elderly patients with peripheral neuropathy 3